Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation (Schedule Of Stock Option Activity) (Details)

v2.4.0.8
Equity-Based Compensation (Schedule Of Stock Option Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 28, 2013
Dec. 29, 2012
Equity-Based Compensation [Abstract]    
Shares, Outstanding 2,689  
Shares, Granted 175  
Shares, Exercised (939)  
Shares, Cancelled (98)  
Shares, Outstanding 1,827 2,689
Shares, Exercisable 540  
Weighted-average grant price, Outstanding $ 34.43  
Weighted-average grant price, Granted $ 53.83  
Weighted-average grant price, Exercised $ 32.20  
Weighted-average grant price, Cancelled $ 35.87  
Weighted-average grant price, Outstanding $ 37.37 $ 34.43
Weighted-average grant price, Exercisable $ 35.73  
Weighted-average remaining contractual term, Outstanding 2 years 7 months 6 days 2 years 10 months 24 days
Weighted-average remaining contractual term, Exercisable 1 year 9 months 18 days  
Aggregate intrinsic value, Outstanding $ 5,136 [1]  
Aggregate intrinsic value, Outstanding 74,160 [1] 5,136 [1]
Aggregate intrinsic value, Exercisable $ 22,678 [1]  
Closing price of common stock $ 77.72 $ 31.60
[1] Aggregate intrinsic value is defined as the difference between the current market value date (the closing price of the Company's common stock on the last trading day of the exercise price of awards that were in-the-money. The closing price of the Company's December 29, 2012 and December 28, 2013, was $31.60 and $77.72, respectively.